UK makes validated stem cells available to therapy developers for £500 per vial

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Cell lines, Cell biology, Cell

Cell therapy developers can source “regulator ready” stem cells from the UK Stem Cell Bank (UKSCB) for a £500 per vial fee under a scheme announced by the MHRA.

The first batch of stem cells were available on Monday​.

The UKSCB said because the cells are made in compliance with the European tissues and cells directive (EUTCD) they are suitable for use as starting materials in manufacturing therapies for clinical trials, adding that this would save developers time and money.

A spokesman told us “the supply process starts with application to the UK Steering Committee​” adding that “once approval is given by the UKSC, and subject to signing the appropriate legal agreements with the Bank and the owner of the cell lines we would then supply the cells in  frozen vials​.”

The current processing charge for frozen vials of the Research-Grade cell lines is £500 ($618) per vial​” he continued.

Data dossier

At present the cell lines come with a Certificate of Analysis (CoA) which provides basic information, however, the UKSCB is working on more detailed data packages tailored to the specific needs of the user involved.

The spokesman said: “If the cells are intended as a starting material for cellular therapy or clinical trial we will be able to supply a cell line dossier which will aid in the regulatory approval process. This dossier is currently under development and will be available later in the year.”

He added that the data dossiers would be available for an additional charge, but did not provide details.

According to the MHRA the stems will be manufactured by researchers at the University of Sheffield, University of Manchester and King's College London.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Related suppliers

Follow us


View more